CANNAPHARMARX INC (CPMD) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
SUITE 3600 CALGARY, AB T2P 5C5 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2,317 | 27,767 | 334,969 | 1,547 | 682,059 | ||||
| Cash and cash equivalents | 2,317 | 27,767 | 334,969 | 1,547 | 682,059 | ||||
| Receivables | 23,251 | 1,771 | 551 | 28,361 | |||||
| Prepaid expense | 68,539 | 132,031 | 592,473 | 134,689 | |||||
| Deposits current assets | 1,308,830 | ||||||||
| Other current assets | 5,906 | ||||||||
| Other undisclosed current assets | 1 | (217,941) | |||||||
| Total current assets: | 100,014 | 29,538 | 467,551 | 1,931,211 | 598,807 | ||||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 5,127,622 | ✕ | ✕ | ||||||
| Property, plant and equipment | 107,780 | 6,032 | 1,568,751 | 1,563,260 | 1,563,260 | ||||
| Intangible assets, net (including goodwill) | 6,370,333 | 6,065,014 | |||||||
| Goodwill | 6,370,333 | 6,065,014 | |||||||
| Other undisclosed noncurrent assets | 78,760 | 78,760 | 6,711,289 | 6,152,610 | 1,871,000 | ||||
| Total noncurrent assets: | 5,314,162 | 84,792 | 8,280,040 | 14,086,203 | 9,499,274 | ||||
| TOTAL ASSETS: | 5,414,176 | 114,330 | 8,747,591 | 16,017,414 | 10,098,081 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 7,224,872 | 3,323,664 | 2,544,325 | 1,120,484 | 1,500,705 | 604,542 | |||
| Interest and dividends payable | ✕ | ✕ | 194,407 | 96,477 | 27,630 | 68,052 | |||
| Accounts payable | 6,882,947 | 3,129,257 | 2,447,848 | 902,854 | 766,203 | ||||
| Accrued liabilities | 151,925 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 190,000 | 190,000 | 666,450 | 604,542 | |||||
| Debt | 8,856,918 | 8,999,336 | 9,726,307 | 1,090,794 | 2,210,975 | ||||
| Derivative instruments and hedges, liabilities | 1,008,868 | 507,494 | 3,676,649 | ||||||
| Estimated litigation liability | 190,000 | ||||||||
| Due to related parties | ✕ | 19,757 | 655,171 | 582,096 | 28,758 | 169,758 | |||
| Other undisclosed current liabilities | 74,496 | 190,000 | 946,738 | 1,158,959 | 2,222,000 | ||||
| Total current liabilities: | 17,165,154 | 13,040,251 | 17,549,190 | 3,952,333 | 5,962,438 | 964,300 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 7,210,883 | 4,421,942 | |||||||
| Long-term debt, excluding current maturities | 7,210,883 | 4,421,942 | |||||||
| Other undisclosed noncurrent liabilities | 5,593,478 | ||||||||
| Total noncurrent liabilities: | 5,593,478 | 7,210,883 | 4,421,942 | ||||||
| Total liabilities: | 22,758,632 | 13,040,251 | 17,549,190 | 11,163,216 | 10,384,380 | 964,300 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (17,344,455) | (12,925,920) | (8,801,599) | 4,854,198 | (286,299) | (964,300) | |||
| Preferred stock | 60,000 | ||||||||
| Common stock | 27,412 | 12,551 | 4,699 | 3,649 | 1,894 | 1,796 | |||
| Treasury stock, value | (13) | (13) | (13) | (13) | |||||
| Additional paid in capital | 74,523,642 | 73,055,579 | 68,336,249 | 61,619,415 | 36,642,276 | 32,930,067 | |||
| Accumulated other comprehensive income (loss) | 240,427 | (371,909) | (345,714) | 137,696 | |||||
| Accumulated deficit | (94,695,339) | (86,164,319) | (77,331,820) | (57,441,549) | (36,990,469) | (33,896,163) | |||
| Other undisclosed equity, attributable to parent | 2,559,416 | 542,191 | 535,000 | 535,000 | |||||
| Other undisclosed equity | (1) | (1) | |||||||
| Total equity: | (17,344,456) | (12,925,921) | (8,801,599) | 4,854,198 | (286,299) | (964,300) | |||
| TOTAL LIABILITIES AND EQUITY: | 5,414,176 | 114,330 | 8,747,591 | 16,017,414 | 10,098,081 | ||||
Income Statement (P&L) (USD)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 402,394 | 63 | ||||||
| Other income | 402,394 | 63 | ||||||
| Gross profit: | 402,394 | 63 | ||||||
| Operating expenses | (5,211,809) | (2,993,169) | (14,486,172) | (15,977,943) | (954,317) | (6,633) | ||
| Other undisclosed operating loss | (402,394) | (63) | ||||||
| Operating loss: | (5,211,809) | (2,993,169) | (14,486,172) | (15,977,943) | (954,317) | (6,633) | ||
| Nonoperating expense | (3,319,211) | (5,839,330) | (5,404,100) | (4,473,137) | (2,139,989) | |||
| Investment income, nonoperating | (6,672,019) | (7,070,841) | ||||||
| Debt instrument, convertible, beneficial conversion feature | 1,357,978 | |||||||
| Interest and debt expense | (929,912) | (2,960,020) | (2,293,858) | (4,473,137) | (2,140,052) | |||
| Loss from continuing operations before equity method investments, income taxes: | (9,460,932) | (11,792,519) | (22,184,130) | (24,924,217) | (5,234,358) | (6,633) | ||
| Other undisclosed income from continuing operations before income taxes | 929,912 | 2,293,858 | 4,473,137 | 2,140,052 | ||||
| Loss from continuing operations: | (8,531,020) | (11,792,519) | (19,890,272) | (20,451,080) | (3,094,306) | (6,633) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (11,792,519) | (19,890,272) | (20,451,080) | (3,094,306) | (6,633) | |
| Other undisclosed net income | 2,960,020 | |||||||
| Net loss: | (8,531,020) | (8,832,499) | (19,890,272) | (20,451,080) | (3,094,306) | (6,633) | ||
| Other undisclosed net income attributable to parent | ||||||||
| Net loss available to common stockholders, diluted: | (8,531,020) | (8,832,499) | (19,890,272) | (20,451,080) | (3,094,306) | (6,633) | ||
Comprehensive Income (USD)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (8,531,020) | (8,832,499) | (19,890,272) | (20,451,080) | (3,094,306) | (6,633) | ||
| Comprehensive loss: | (8,531,020) | (8,832,499) | (19,890,272) | (20,451,080) | (3,094,306) | (6,633) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 612,335 | (26,195) | (483,409) | 137,694 | ||||
| Comprehensive loss, net of tax, attributable to parent: | (7,918,685) | (8,858,694) | (20,373,681) | (20,313,386) | (3,094,306) | (6,633) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.